Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology (Q36237461)

12 August 2017

Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology (English)

1 reference

12 August 2017

1 reference

Anobel Y Odisho

1

0 references

Matthew R Cooperberg

object named as

Matthew R Cooperberg

4

0 references

author name string

Anna B Berry

2

1 reference

12 August 2017

Ardalan E Ahmad

3

1 reference

12 August 2017

Peter R Carroll

5

1 reference

12 August 2017

Badrinath R Konety

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

14 April 2012

1 reference

12 August 2017

1 reference

12 August 2017

63

1 reference

12 August 2017

5

1 reference

12 August 2017

936-940

1 reference

Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Guidelines on bladder cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Diagnostic significance of atypical category in the voided urine samples: A retrospective study in a tertiary care center

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Clinical model of cost of bladder cancer in the elderly

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

uCyt test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443544

Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis

22 September 2018

1 reference

12 December 2020

Use of urinary biomarkers for bladder cancer surveillance: patient perspectives

1 reference

12 December 2020

uCyt /ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses

1 reference

12 December 2020

Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark

1 reference

12 December 2020

Urine cytology discrepancies: frequency, causes, and outcomes

1 reference

12 December 2020

Diagnostic significance of 'atypia' in instrumented versus voided urine specimens

1 reference

12 December 2020

Analysis of atypical urine cytology in a tertiary care center

1 reference

12 December 2020

ImmunoCyt/uCyt improves the sensitivity of urine cytology in patients followed for urothelial carcinoma

1 reference

12 December 2020

Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings

1 reference

12 December 2020

Immunocytology in the assessment of patients with asymptomatic microhaematuria

1 reference

12 December 2020

Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States

1 reference

12 December 2020

The value of the ImmunoCyt/uCyt test in the detection and follow-up of carcinoma in situ of the urinary bladder

1 reference

12 December 2020

10.1016/J.EURURO.2012.04.019

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22521093

1 reference